Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Molecular Mechanisms of Mast Cell Activation by Cholesterol-Dependent Cytolysins

L. Draberova, M. Tumova, P. Draber

. 2021 ; 12 (-) : 670205. [pub] 20210623

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22004189

Mast cells are potent immune sensors of the tissue microenvironment. Within seconds of activation, they release various preformed biologically active products and initiate the process of de novo synthesis of cytokines, chemokines, and other inflammatory mediators. This process is regulated at multiple levels. Besides the extensively studied IgE and IgG receptors, toll-like receptors, MRGPR, and other protein receptor signaling pathways, there is a critical activation pathway based on cholesterol-dependent, pore-forming cytolytic exotoxins produced by Gram-positive bacterial pathogens. This pathway is initiated by binding the exotoxins to the cholesterol-rich membrane, followed by their dimerization, multimerization, pre-pore formation, and pore formation. At low sublytic concentrations, the exotoxins induce mast cell activation, including degranulation, intracellular calcium concentration changes, and transcriptional activation, resulting in production of cytokines and other inflammatory mediators. Higher toxin concentrations lead to cell death. Similar activation events are observed when mast cells are exposed to sublytic concentrations of saponins or some other compounds interfering with the membrane integrity. We review the molecular mechanisms of mast cell activation by pore-forming bacterial exotoxins, and other compounds inducing cholesterol-dependent plasma membrane perturbations. We discuss the importance of these signaling pathways in innate and acquired immunity.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004189
003      
CZ-PrNML
005      
20220127145444.0
007      
ta
008      
220113s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fimmu.2021.670205 $2 doi
035    __
$a (PubMed)34248949
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Draberova, Lubica $u Department of Signal Transduction, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia
245    10
$a Molecular Mechanisms of Mast Cell Activation by Cholesterol-Dependent Cytolysins / $c L. Draberova, M. Tumova, P. Draber
520    9_
$a Mast cells are potent immune sensors of the tissue microenvironment. Within seconds of activation, they release various preformed biologically active products and initiate the process of de novo synthesis of cytokines, chemokines, and other inflammatory mediators. This process is regulated at multiple levels. Besides the extensively studied IgE and IgG receptors, toll-like receptors, MRGPR, and other protein receptor signaling pathways, there is a critical activation pathway based on cholesterol-dependent, pore-forming cytolytic exotoxins produced by Gram-positive bacterial pathogens. This pathway is initiated by binding the exotoxins to the cholesterol-rich membrane, followed by their dimerization, multimerization, pre-pore formation, and pore formation. At low sublytic concentrations, the exotoxins induce mast cell activation, including degranulation, intracellular calcium concentration changes, and transcriptional activation, resulting in production of cytokines and other inflammatory mediators. Higher toxin concentrations lead to cell death. Similar activation events are observed when mast cells are exposed to sublytic concentrations of saponins or some other compounds interfering with the membrane integrity. We review the molecular mechanisms of mast cell activation by pore-forming bacterial exotoxins, and other compounds inducing cholesterol-dependent plasma membrane perturbations. We discuss the importance of these signaling pathways in innate and acquired immunity.
650    _2
$a zvířata $7 D000818
650    _2
$a vápníková signalizace $7 D020013
650    _2
$a buněčná smrt $7 D016923
650    _2
$a degranulace buněk $7 D015550
650    _2
$a buněčná membrána $x imunologie $x metabolismus $x mikrobiologie $x patologie $7 D002462
650    _2
$a buněčné mikroprostředí $7 D060833
650    _2
$a cholesterol $x metabolismus $7 D002784
650    _2
$a cytokiny $x metabolismus $7 D016207
650    _2
$a cytotoxiny $x metabolismus $7 D003603
650    _2
$a grampozitivní bakterie $x imunologie $x metabolismus $7 D006094
650    _2
$a grampozitivní bakteriální infekce $x imunologie $x metabolismus $x mikrobiologie $x patologie $7 D016908
650    _2
$a interakce hostitele a patogenu $7 D054884
650    _2
$a lidé $7 D006801
650    _2
$a mediátory zánětu $x metabolismus $7 D018836
650    _2
$a mastocyty $x imunologie $x metabolismus $x mikrobiologie $x patologie $7 D008407
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Tumova, Magda $u Department of Signal Transduction, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia
700    1_
$a Draber, Petr $u Department of Signal Transduction, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia
773    0_
$w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 12, č. - (2021), s. 670205
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34248949 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145440 $b ABA008
999    __
$a ok $b bmc $g 1751596 $s 1155338
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 12 $c - $d 670205 $e 20210623 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...